Jobs / United States / Novartis Pharmaceuticals Corporation
Principal Scientist – Analytics Team Lead
Novartis Pharmaceuticals Corporation · 🇺🇸 Cambridge (USA)
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Novartis Pharmaceuticals Corporation
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →
About the role
Job Description Summary The Biologics Research Center (BRC) at Novartis BioMedical Research is looking for a motivated and highly experienced leader in field of Physical Chemistry Analytics (PCA) and Mass Spectrometry (MS) to join BRC’s Analytics, Bioanalytics and Formulation unit and help us develop a diverse portfolio of biotherapeutic modalities. Job Description Internal Job Title: Principal Scientist I/II Position Location: Cambridge, MA, onsite The Biologics Research Center (BRC) at Novartis BioMedical Research is looking for a motivated and highly experienced leader in field of Physical Chemistry Analytics (PCA) and Mass Spectrometry (MS) to join BRC’s Analytics, Bioanalytics and Formulation unit and help us develop a diverse portfolio of biotherapeutic modalities. As a Team Lead for the analytics team, you will demonstrate a broad and in-depth knowledge of technologies in PCA and MS to evaluate the developability of various biologics modalities covered by BRC ranging from traditional antibodies to gene therapy viral vector, ensuring quality of material delivered and eventually enabling candidate selection. You will lead a team of up to 5 associates where you will be responsible for a continuously strong culture of team spirit and integrity, as well as providing development opportunities for associates on different levels. Key responsibilities: • Drive the analytics (PCA and MS) strategy in Cambridge, working globally in a matrix organization to support a diverse biologics pipeline (e.g. antibodies, fusion proteins, ADCs, bi- and trispecifics, AAVs, Lentiviruses) transitioning into clinical development • Act as senior analytics expert in project teams ensuring optimal project support and high quality for all deliverables of your group • Foster streamlined processes and optimal use of capacities as well as continued innovation, incorporating latest technologies and knowledge • Effectively manage resources, project activities, timelines, maintain a strong customer focus and set respective objectives for your team • Provide leadership and clear guidance to the team, optimally leveraging the expertise and experience of individuals • Drive a culture of collaboration, integrity, and team development, and ensure a safe, empowering, and inspiring working environment Essential Requirements : • PhD degree or equivalent in biochemistry, biotechnology, chemistry or a related field with 3+ years of related experience in the pharmaceutical industry, with 2+ years of experience as a people manager • Strong scientific background in analysis of recombinant proteins (mAb, bi/tri-specific mAbs, therapeutic proteins) by techniques such as mass spectrometry, chromatography, capillary electrophoresis, and light scattering technologies • Implementation and supervision of cutting-edge characterization of PCA techniques for analyzing novel biologics modalities, e.g. multispecific Abs, AAV, ADCs, oligonucleotides, CAR-T’s. This entails the evaluation of novel instrumentation and the development of new applications to existing technologies such as dynamic light scattering, chromatography (SEC, HIC, IEX, RPC), MALS, capillary electrophoresis (cIEF, CZE, CE-SDS), and other advanced technologies • Experience with modern LC-MS techniques (Intact/reduced/subunit RPMS, peptide mapping, released glycans), managing instrumentation (orbitraps, QTOFs) and modern hyphenated MS techniques (SEC-MS, CE-MS). Experience interpreting CDMS results for AAV analysis is beneficial, direct instrument experience not required • Experience with data analysis workflows and report generation • Proven ability to lead, coach and develop people • Distinguished team spirit and scientific drive • High flexibility combined with excellent organizational and